Silencing of EGFR by siRNA efficiently reduced its expression (Figure 3C) and strongly decreased the phosphorylation of both ERK1/2 and AKT (Figure 3C), confirming the key role of EGFR in the activation of downstream signaling pathways in HEMC-SS chondrosarcoma cells. The gene discussed is MAPK3; the disease is chondrosarcoma.